Vila A, Abal M, Muinelo-Romay L, Rodriguez-Abreu C, Rivas J, López-López R, Costa C. EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation. PLoS One. 2016 Oct 6;11(10):e0163705. doi: 10.1371/journal.pone.0163705.
PMID: 27711186 IF: 3,7 Q1 Onco Clin
León-Mateos L, Vieito M, Anido U, López López R, Muinelo Romay L.
Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.
Int J Mol Sci. 2016 Sep 20;17(9). pii: E1580. IF: 3,2 Q2 BL
Rapado-González Ó, Majem B, Muinelo-Romay L, López-López R, Suarez-Cunqueiro MM. Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity. Int J Mol Sci. 2016 Sep 12;17(9). pii: E1531. doi: 10.3390/ijms17091531. IF: 3,2 Q2 BL
Mota A, Colás E, García-Sanz P, Campoy I, Rojo-Sebastián A, Gatius S, García Á, Chiva L, Alonso S, Gil-Moreno A, González-Tallada X, Díaz-Feijoo B, Vidal A, Ziober-Malinowska P, Bobi?ski M, López-López R, Abal M, Reventós J, Matias-Guiu X, Moreno-Bueno G. Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers. Mod Pathol. 2016 Sep 2. doi: 10.1038/modpathol.2016.143. [Epub ahead of print] IF:6,3 D1 BL
Moran S, Martínez-Cardús A, Sayols S, Musulén E, Balañá C, Estival-Gonzalez A, Moutinho C, Heyn H, Diaz-Lagares A, de Moura MC, Stella GM, Comoglio PM, Ruiz-Miró M, Matias-Guiu X, Pazo-Cid R, Antón A, Lopez-Lopez R, Soler G, Longo F, Guerra I, Fernandez S, Assenov Y, Plass C, Morales R, Carles J, Bowtell D, Mileshkin L, Sia D, Tothill R, Tabernero J, Llovet JM, Esteller M.
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Lancet Oncol. 2016 Oct;17(10):1386-1395. doi: 10.1016/S1470-2045(16)30297-2. PMID: 27575023 IF 24,7 D1 EPI
Folprecht G, Pericay C, Saunders MP, Thomas A, Lopez Lopez R, Roh JK, Chistyakov V, Höhler T, Kim JS, Hofheinz RD, Ackland SP, Swinson D, Kopp M, Udovitsa D, Hall M, Iveson T, Vogel A, Zalcberg JR. Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.
Ann Oncol. 2016 Jul;27(7):1273-9. doi: 10.1093/annonc/mdw176. PMID:27091810 IF 6,5 D1 Onco Clin
Roel M, Rubiolo JA, Guerra-Varela J, Silva SB, Thomas OP, Cabezas-Sainz P, Sánchez L, López R, Botana LM.
Marine guanidine alkaloids crambescidins inhibit tumor growth and activate intrinsic apoptotic signaling inducing tumor regression in a colorectal carcinoma zebrafish xenograft model. Oncotarget. 2016 Nov 4. doi: 10.18632/oncotarget.13068.[Epub ahead of print]
PMID:27825113 IF: 6.35, Q1 Cancer Modeling
González-Martín A, Alba E, Ciruelos E, Cortés J, Llombart A, Lluch A, Andrés R, Álvarez I, Aramendía JM, de la Peña FA, Barnadas A, Batista N, Calvo L, Galve E, García-Palomo A, García-Sáenz JÁ, de la Haba J, López R, López-Vivanco G, Martínez-Jáñez N, de Dueñas EM, Plazaola A, Rodríguez-Lescure Á, Ruiz M, Sánchez-Rovira P, Santaballa A, Seguí MÁ, Tusquets I, Zamora P, Martín M.
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.
Curr Cancer Drug Targets. 2016;16(5):415-28. Review IF 1,7 Oncol Clin
Alonso-Nocelo M, Abuín C, López-López R, de la Fuente M. Development and characterization of a three-dimensional co-culture model of tumor T cell infiltration. Biofabrication. 2016 Apr 14;8(2):025002. doi: 10.1088/1758-5090/8/2/025002. PMID:27078888 IF 4,3 D1 Cancer Model
Espinosa E, Soriano V, Malvehy J, Berrocal A, Martínez de Prado P, Quindós M, Soria A, Márquez-Rodas I, Palacio I, Cerezuela P, López-Vivanco G, Alonso L, Samaniego E, Ballesteros A, Puértolas T, Díaz-Beveridge R, de la Cruz-Merino L, López Castro R, López López R, Stevinson K, Del Barrio P, Tornamira MV, Guillém V, Martín-Algarra S. Treatment patterns of adjuvant interferon-?2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study.
Melanoma Res. 2016 Jun;26(3):278-83. doi: 10.1097/CMR.0000000000000254. PMID:26958991 IF 2,1 Q2 Oncol Clin
Moran S, Martínez-Cardús A, Sayols S, Musulén E, Balañá C, Estival-Gonzalez A, Moutinho C, Heyn H, Diaz-Lagares A, de Moura MC, Stella GM, Comoglio PM, Ruiz-Miró M, Matias-Guiu X, Pazo-Cid R, Antón A, Lopez-Lopez R, Soler G, Longo F, Guerra I, Fernandez S, Assenov Y, Plass C, Morales R, Carles J, Bowtell D, Mileshkin L, Sia D, Tothill R, Tabernero J, Llovet JM, Esteller M.
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Lancet Oncol. 2016 Oct;17(10):1386-1395. doi: 10.1016/S1470-2045(16)30297-2. PMID:27575023 IF 24,7 D1 Oncol Clin
Lorenzo-López L, López-López R, Maseda A, Diego-Díez C, Gómez-Caamaño S, Millán-Calenti JC. Prevalence and Clinical Characteristics of Prefrailty in Elderly Adults: Differences According to Degree of Urbanization. J Am Geriatr Soc. 2016 Jan;64(1):221-3. doi. PubMed PMID: 26782886. IF:4.57, D1 Oncol Clin
De Las Peñas R, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Álvarez Y, Rodríguez CA, Virizuela JA, López López R. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan. Support Care Cancer. 2016 Jan;24(1):499-507. PMID: 26431960; 2015. IF: 2.33, Q1 Oncol Cin